Rose Hill

Rose Hill Acquisition Corporation was a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, share exchange, asset acquisition, or similar business combination with one or more businesses. While the company maintained a broad mandate, it specifically targeted high-growth companies in Latin America, with a particular interest in the healthcare and technology sectors. In 2023, the company entered into a definitive business combination agreement with Invo Bioscience, a healthcare services company focused on expanding access to advanced fertility treatment. However, the SPAC ultimately faced liquidation after failing to complete a business combination within its required timeframe.